Genix Pharmaceuticals Corporation
GENPF
$0.01
-$0.02-53.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.38% | -66.12% | 51.52% | -166.93% | 288.00% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -400.00% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | -75.00% | -- |
| Total Other Non-Cash Items | 34.74% | 47.37% | -37.80% | 120.28% | -790.42% |
| Change in Net Operating Assets | -86.96% | 234.55% | 296.43% | -112.07% | 954.55% |
| Cash from Operations | -96.49% | -14.00% | 77.48% | -50.00% | 11.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -93.13% | 3.90% | -71.90% | 31.73% | -10.73% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 330.77% | 8.33% | -72.02% | 26.56% | -10.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13,950.00% | -75.00% | 113.79% | -744.44% | 80.00% |